Effectiveness of progesterone, Duphaston, and placebo to prevent preterm birth

Phase 3

• Conditions: Preterm labor.; Preterm labor

• Registration Number: IRCT20180303038922N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

Gestational age between 24-34 weeks
Maternal age between 18-37 years old
Singleton pregnancy
Contractions occur one to eight minutes apart.
Dilatation less than 3 cm.
Effacement less than 80 percent
intact amniotic membrane

Exclusion Criteria

Maternal or fetal conditions that necessitate urgent delivery
fetal anomalies
Evidence for tocolytic drug contraindication
Allergy to progestrone

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
terine contractions. Timepoint: every 2 weeks until 36 weeks and then weekly. Method of measurement: Uterine contractions are measured by Cardiotachometer.

Secondary Outcome Measures

Name	Time	Method
Gestational age at labor. Timepoint: every 2 weeks until 36 weeks and then weekly. Method of measurement: gestational age in weeks (based on first trimester ultrasound).